Collaboration agreement between the CIDEM-PCB Bioincubator of the Parc Científic de Barcelona and an incubator in Québec Blog Post

On 12th September, the CIDEM-PCB Bioincubator of the Parc Científic de Barcelona (PCB, Barcelona Science Park) and the business incubator Quebec Biotechnology Innovation Centre (), located in the of Laval Island (Quebec), signed a collaboration agreement which aims to strengthen new cooperation models that support the creation of new enterprises.

19 October: World Breast Cancer Day

Saturday 19 October is World Breast Cancer Day, a day dedicated to raising awareness of the importance of early diagnosis in the fight against this type of cancer, the most…

A project led by IBMB-CSIC tests molecules that stop the cytokine storm caused by SARS-CoV-2 Blog Post

A team of researchers led by Timothy Thomson’s group from the Barcelona Institute of Molecular Biology (IBMB-CSIC), based at the Barcelona Science Park, has developed a platform that allows to see in real-time if a drug inhibits the immune cellular response caused by SARS-CoV-2 infection. The project has the advantage that all the molecules being tested are previously known drugs and compounds that are used for other clinical indications. This would expedite the necessary procedures to propose, in due course, the use in patients with COVID-19.

 

Moirai Biodesign developes a diagnostic kit for the detection of sepsis in three hours Blog Post

Moirai Biodesign, a biotech start-up based in the Barcelona Science Park, has developed a prototype ‘kit’ based on biosensors that analyzes a blood sample and identifiesthe most important sepsis-causing pathogens and their associated antibiotic resistances, at the point of care and directly from the patient’s blood, in just three hours, a process that usually requires up to 5 days of analysis in the laboratory. The company has just received a €75,000 grant through the Startup Capital financing line from ACCIÓ to  to set about the activities derived from the execution of the initial business plan. Its objective is to market this device in hospitals, once the validation phase is completed.The kit will allow identification 

Scott Boyer joins Chemotargets as new CEO Blog Post

Chemotargets, a global leader in predictive analytics solutions for the pharma and biotech sector, has appointed Dr. Scott Boyer as new CEO. He takes over from Dr. Jordi Mestres, who becomes Chief Scientific Officer and will maintain his position as President of the Board. With the new incorporation, the company, based in the Barcelona Science Park, consolidates its transition from a software business to an AI-driven biotech company.

 

IBEC researcher Pere Roca-Cusachs joins the European elite club in biology Blog Post

Pere Roca-Cusachs –group leader at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and associate professor at the Faculty of Medicine of the University of Barcelona (UB)– has been chosen to join the European Molecular Biology Organization (EMBO), a prestigious network that brings together some of the most brilliant researchers in the world.